Children’s Hospital LA Starts Valentine Card Campaign
Children’s Hospital Los Angeles Launches Annual Valentine’s Day Card Drive with Space-Themed Fun and Community Giving Children’s Hospital Los Angeles (CHLA) is once again inviting the community to share love, encouragement, and kindness through its beloved annual Valentine’s Day card…
Guardian Dermatology Partners with Epiphany Dermatology
Partnership Improves Access to Exceptional Dermatologic Care Epiphany Dermatology, a leading dermatology organization dedicated to expanding access to high-quality, patient-centered skin care, today announced the continued growth of its footprint in the Montana market through a new partnership with Guardian…
U.S. Physical Therapy Acquires Industrial Injury Prevention Firm
U.S. Physical Therapy Expands Industrial Injury Prevention Portfolio with New Acquisition Physical Therapy, a leading national provider of outpatient physical therapy services and a growing force in industrial injury prevention, has announced the acquisition of a specialized industrial injury prevention…
Serenity Mental Health Broadens Psychiatric Services in Las Vegas
Serenity Mental Health Centers Expands Comprehensive Psychiatric Services in Las Vegas Serenity Mental Health Centers, recognized as a leader in modern psychiatric care and one of the fastest-growing mental health providers in the United States, has announced a significant expansion…
Biocodex Launches Fullify™, Precision Probiotic for Gut-Brain Appetite Support
Biocodex Debuts Fullify, Clinically Proven Probiotic for Appetite Control In a category often crowded with quick fixes, stimulants, and short-term appetite suppressants, Biocodex is introducing a markedly different philosophy to weight and appetite management — one grounded in biology rather…
Quince Announces Phase 3 Results for A-T Therapy eDSP
vQuince Therapeutics Reports Topline Results from Phase 3 NEAT Trial of eDSP in Ataxia-Telangiectasia Quince Therapeutics a late-stage biotechnology company focused on developing therapies for rare diseases by leveraging the biology of a patient’s own cells, has announced topline results…
Drug-Free Emotion Therapy Begins Pilot Amid Mental Health System Upheaval
Drug-Free Emotional Regulation Pilot Launches in California as U.S. Mental Health System Faces Mounting Strain At a time when the U.S. mental health system is grappling with persistent funding instability, workforce burnout, and a sharp rise in demand for accessible…
AHF Challenges Florida Health Dept Over HIV Treatment Cuts
AHF Files Legal Petition Challenging Florida Health Department Over HIV Treatment Rule Changes A major legal dispute is unfolding in Florida after the AIDS Healthcare Foundation (AHF) filed a petition against the state’s Department of Health (DOH), alleging that newly…
Innovaccer Introduces AI Solutions Amid Healthcare Challenges
Innovaccer Showcases Expanding AI Ecosystem as Healthcare Leaders Confront Workforce, Financial, and Administrative Pressures at Xccelerate 2026 Innovaccer, a healthcare AI company focused on data unification and intelligent automation, concluded its annual customer and industry conference, Xccelerate 2026, bringing together…
USDTL and CourtFact Partner to Simplify Drug Testing & Case Management
USDTL and CourtFact Form Strategic Integration Partnership to Enhance Drug Testing and Case Management Services United States Drug Testing Laboratories (USDTL), a nationally recognized leader in forensic and clinical toxicology, has announced a significant new integration partnership with CourtFact, a…
INOVAIT Invites Applications for Image-Guided Therapy and AI Innovation Projects
INOVAIT Launches Winter 2026 Pilot Fund Call for Applications to Advance AI and Image-Guided Therapy Innovations INOVAIT, Canada’s leading network for image-guided therapy (IGT) and artificial intelligence (AI), has opened a new call for applications for its Winter 2026 Pilot…
Michael Iskra Takes Helm at Cleveland Diagnostics to Accelerate Growth Post-IsoPSA FDA Approval
Cleveland Diagnostics Appoints Michael Iskra as CEO to Accelerate Growth Following FDA Approval of IsoPSA® Assay Cleveland Diagnostics, a pioneering commercial-stage precision oncology company, has announced the appointment of Michael Iskra as its new Chief Executive Officer. With more than…